Reviews

Strategic Conception for AI-driven Inheritance and Innovation of Min-Tai Herbal Medicine Intangible Cultural Heritage

Expand
  • (School of Pharmaceutical Sciences, Xiamen University, Xiamen 361105, Fujian China)

Received date: 2025-10-27

  Accepted date: 2026-01-12

  Online published: 2026-04-30

Abstract

The intangible cultural heritage of Min-Tai (Fujian and Taiwan) herbal medicine, which integrates traditional Chinese medicine theories with the regional wisdom of Fujian and Taiwan, currently faces multiple challenges such as a gap in inheritance, declining application, low industrial aggregation, and insufficient scientific research. From the perspective of model innovation, this paper points out that the root of these challenges lies in the inherent conflict between the individualized experience of agricultural civilization and the standardized model of industrial civilization. This paper proposes a strategy driven by artificial intelligence and big data technology, following a three-stage path of 'credit-confidence-conviction' to build a real-world data platform and an AI-assisted diagnosis and treatment system. This approach aims to elevate Min-Tai herbal medicine from traditional experience to intelligent, personalized services, achieving a transformation. The paper demonstrates the value of this transformation from cultural, technological, clinical, and industrial perspectives, offering systematic solutions for the preservation and innovative development of this intangible cultural heritage. It also provides significant reference for advancing the modernization of regional traditional Chinese medicine and implementing the 'Healthy China' and 'Digital China' strategies.

Cite this article

QIU Ying-kun . Strategic Conception for AI-driven Inheritance and Innovation of Min-Tai Herbal Medicine Intangible Cultural Heritage[J]. Subtropical Plant Science, 2026 , 55(2) : 249 -254 . DOI: 10.3969/j.issn.1009-7791.2026.02.013

References

[1]  李丹婷. 深化闽台中医药融合发展的若干思考[J]. 中医药管理杂志, 2021, 29(13): 243–246.

[2]  许克祥, 黄国辉. 闽台中药产业市场发展困境原因探析[J]. 海峡科学, 2013(5): 43–45.

[3]  国务院. 国务院关于印发中医药发展战略规划纲要(2016 —2030年)的通知[EB/OL]. (2016-02-26)[2025-10-27]. https:// www.gov.cn/zhengce/zhengceku/2016-02/26/content_5046678.htm

[4]  胡慧娟. 闽台吴夲信仰与健康文化传播研究[D]. 漳州: 闽南师范大学硕士学位论文, 2024.

[5]  张元一, 彭榕华. 试论闽台医缘关系[J]. 福建史志, 2025, 245(2): 21–29.

[6]  福建省人民政府办公厅. 福建省“十四五”中医药健康发展规划[Z]. 2022.

[7]  任娟莉, 任杰. 太白草药医学的历史文化价值[J]. 陕西中医, 2013, 34(7): 935–937.

[8]  屠呦呦, 倪慕云, 钟裕容. 中药青蒿化学成分的研究Ⅰ[J]. 药学学报, 1981(5): 366–370.

[9]  新华社. 中共中央 国务院印发《“健康中国2030”规划纲要》[N]. 人民日报, 2016-10-26(1).

[10]  黄璐琦. 将中医药融入创新驱动战略[N]. 中国科学报, 2017-6-28(1).

[11]  Yun D Y, Wu X H, Chen X, Yang Y H, Shang Y J, Liu S P, Gunasekeran D V, Lin D R, Liu L X, Zhao L Q, Chen W B, Chen J J, Jin L, Wu Y X, Hong J M, Hu W L, Lin Z Z, Cheung C Y, Chen X, Xie P C, Liu Z Z, Ding C H, Yu-Wai-Man P, Yu K N, Shu W T, Liu Y Z, Zheng Z B, Zhao G S, Xa Z H, Wong T Y, Lin H T. An artificial intelligence and blockchain technology-based data management framework for multicenter randomized controlled trials [J]. Science Bulletin, 2025, 70(6): 856–860.

Outlines

/

〈 〉